Preventing Stroke Triggers in Children With Sickle Cell Anaemia in Mulago Hospital, Kampala (PREST ): a Randomized Control Trial

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 150 participants.

Also called NCT03666806

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose prevention
Phase
Phase 2/3
Enrolled
  • 150 participants (planned count) (from the registry)
Sponsor
Makerere University (from the registry)
Registry
  • NCT NCT03666806
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Uganda (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT03666806. Randomized; quadruple masking; primary purpose prevention. Start 2018-08-22 (actual); primary completion 2019-09 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Preventing Stroke Triggers in Children With Sickle Cell Anaemia in Mulago Hospital, Kampala (PREST ): a Randomized Control Trial
Acronym
PREST
Condition
Preventing Stroke in Sickle Cell Anaemia
Intervention (Biological)
Influenza vaccine
Lead sponsor
Makerere University (class: other)

Record details

Record id
cardio:ct-nct03666806
Content hash
6881a213a11f568a1ef92d20523a135db1c3615b10c0b260e85c921bc3aa6ec9